Global Cancer Gene Therapy Market 2017-2021
- SKU ID : TNV-IRTNTR14197 10986418
- |
- Publishing Date: 09-Aug-2017
- |
- Region: Global
- |
- No. of pages: 85
About Cancer Gene Therapy
Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual's body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses.
Technavio’s analysts forecast the global cancer gene therapy market to grow at a CAGR of 20.63% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer gene therapy market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cancer Gene Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Adaptimmune
• bluebird bio
• Celgene
• Shanghai Sunway Biotech
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
Other prominent vendors
• Altor BioScience
• Amgen
• argenx
• BioCancell
• GlaxoSmithKline
• Merck
• OncoGenex Pharmaceuticals
• Transgene
Market driver
• Rising geriatric population
• For a full, detailed list, view our report
Market challenge
• High cost of gene therapy treatment
• For a full, detailed list, view our report
Market trend
• Favorable government regulations for gene therapy programs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual's body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses.
Technavio’s analysts forecast the global cancer gene therapy market to grow at a CAGR of 20.63% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer gene therapy market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cancer Gene Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Adaptimmune
• bluebird bio
• Celgene
• Shanghai Sunway Biotech
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
Other prominent vendors
• Altor BioScience
• Amgen
• argenx
• BioCancell
• GlaxoSmithKline
• Merck
• OncoGenex Pharmaceuticals
• Transgene
Market driver
• Rising geriatric population
• For a full, detailed list, view our report
Market challenge
• High cost of gene therapy treatment
• For a full, detailed list, view our report
Market trend
• Favorable government regulations for gene therapy programs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
